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The open reading frame EP153R, located within the EcoRI E9 fragment of the African swine fever (ASF) virus genome, is
predicted to encode a membrane protein of 153 amino acids that presents significant homology to the N-terminal region of
several CD44 molecules. EP153R contains multiple putative sites for N-glycosylation, phosphorylation, and myristoylation, a
central transmembrane region, a C-type animal lectin-like domain, and a cell attachment sequence. Transcription of EP153R
takes place at both early and late times during the virus infection. The disruption of the gene, achieved by insertion of the
marker gene LacZ within EP153R, did not change either the in vitro virus growth rate or the virus-sensitive/resistant condition
of up to 17 established cell lines, but abrogated the hemadsorption phenomenon induced in ASF virus-infected cells. As the
sequence and expression of the ASF virus protein pEP402R, a CD2 homolog responsible for the adhesion of erythrocytes to
susceptible cells, was unaffected in cultures infected with the EP153R deletion mutant, we conclude that the gene EP153R
is needed to induce and/or maintain the interaction between the viral CD2 homolog and its corresponding cell receptor.
© 2000 Academic PressINTRODUCTION
African swine fever (ASF) virus, a large enveloped
deoxyvirus, is the causative agent of an important
disease of domestic pigs (reviewed in Hess, 1981;
Vin˜uela, 1987; Costa, 1990). The virus contains a dou-
ble-stranded DNA molecule ranging in size between
170 and 190 kbp depending on the virus strain (Blasco
et al., 1989) and about 34 structural proteins with
molecular masses of 10 to 150 kDa (Carrascosa et al.,
1985). The ASF virus infects only species of the Suidae
family and ticks of the Ornithodoros genus (Argasidae
family) (Vin˜uela, 1985; Wilkinson, 1989). In domestic
pigs the virus is associated mainly with tissue macro-
phages and blood monocytes (Malmquist and Hay,
1960; Plowright et al., 1968) and to a lesser extent, with
reticular cells, polymorphs, and megakaryocytes
(Casal et al., 1984; Wilkinson, 1989).
One characteristic feature of the cells infected with
ASF virus field isolates is the ability to adsorb swine
erythrocytes (hemadsorption) on its surface (Malmquist
and Hay, 1960), a property successfully exploited to dif-
ferentiate the ASF virus from other agents that produced
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34diseases with symptoms likely to be confused with those
observed in ASF (Hess and De Tray, 1960) and to develop
specific techniques for ASF virus titration (Enjuanes et
al., 1976).
The analysis of the complete sequence of ASF virus
strain BA71V (Ya´n˜ez et al., 1995) has greatly expanded
our knowledge about the possible role of many of the 151
open reading frames contained in the ASF virus genome.
A virus protein, homologous to the CD2 adhesion recep-
tor of T cells, encoded by the EP402R gene, has been
directly involved in the hemadsorption phenomenon in-
duced by the ASF virus in the infected cell (Rodrı´guez et
al., 1993). Another ASF virus-encoded protein that could
be important in the control of the adhesion ability of
infected cells is pEP153R, which contains a central trans-
membrane region, a C-type animal lectin-like domain,
and a cell attachment (RGD) sequence (Ya´n˜ez et al.,
1995). In this report we present a comparison of the
amino acid sequence of pEP153R and several CD44
molecules, along with experiments describing the tran-
scriptional expression of the viral gene EP153R during
infection of cultured cells. The disruption of the gene
proved that protein pEP153R is required, in addition to
the viral CD2 homolog pEP402R, to accomplish effi-
ciently the process of hemadsorption in ASF virus-in-
fected cells, revealing a role in the regulation (stabiliza-
tion) of the interaction of CD2 with the corresponding cell
receptor, as has been described for the CD2-mediated
binding of human erythrocytes to human T cells (Haynes
et al., 1989).
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341AFRICAN SWINE FEVER VIRUS EP153R ORFRESULTS
roperties of EP153R ORF
The EP153R ORF is located within the EcoRI E9
enomic fragment of the BA71V strain of the ASF virus
Fig. 1A) and encodes a protein, designated pEP153R, of
53 amino acids with a predicted molecular size of 18
Da. The analysis of the sequence (Fig. 1B) revealed
ight possible sites for N-glycosylation, three for phos-
horylation, and two for myristoylation, in addition to the
rg-Gly-Asp (RGD) motif for integrin recognition. The
ydropathy profile of pEP153R (Fig. 1C) resembled that of
typical class II transmembrane protein (Singer et al.,
987) containing three domains: (i) a hydrophilic seg-
ent of 27 amino acids in the N-terminal end of the
rotein, (ii) a hydrophobic stretch (positions 28 to 50) that
ould act as a transmembrane domain, and (iii) a hydro-
hilic section of 103 residues in the C-terminal region of
he polypeptide.
ranscriptional analysis of EP153R
Transcription of the EP153R ORF was studied by
orthern blot and primer extension analyses. For these
xperiments, RNA was prepared from Vero cells either
ock-infected or infected with ASF virus in the presence
r in the absence of cycloheximide and citosine arabi-
oside, as described under Materials and Methods.
Northern blot hybridization was performed with a 32P-
end-labeled oligonucleotide complementary to the
mRNA of EP153R. The probe recognized three RNA spe-
cies of 0.7, 2.3, and 2.7 kb synthesized during the imme-
diate-early and early phases of infection, and four tran-
scripts of about 0.6, 1.0, 2.2, and 2.6 kb in the virus-
induced late RNA sample (Fig. 2B).
To map the 59-end of the EP153R transcription product,
a primer extension analysis was performed, using as a
primer the same oligonucleotide used in Northern blot
hybridization. The results from the primer extension re-
vealed a major product of 279 nucleotides in the samples
of both immediate-early and early RNA, which corre-
sponded to an initiation of transcription at position 2164
relative to the first nucleotide of the EP153R ORF (Figs.
2A and 2C). A minor band of 179 nucleotides was de-
tected with the late RNA sample, indicating the existence
of a late mRNA initiating at 64 nucleotides upstream of
EP153R (Figs. 2A and 2C). The transcripts of 0.7 and 0.6
kb, detected by Northern blot in the early and late RNA
samples, respectively, would correspond to those de-
tected in the primer extension if, as expected, their 39-
ends map at the first motif of 7 consecutive thymidilate
residues (7T) (Figs. 2C and 2D), a sequence that has
been found to be associated with the 39-end formation of
both early and late ASF virus mRNAs (Almaza´n et al.,
1992, 1993). In addition, the longer transcripts detected
by Northern blot could be explained by the existence ofread-through transcripts (from EP402R and EP153R) end-
ing in different stretches of 7T (Fig. 2D).
Homology of protein pEP153R with C-type animal
lectins and with the N-terminal region of
CD44 molecules
A search of the data bases carried out with the FASTA
program (Pearson and Lipman, 1988) revealed that pro-
tein pEP153R displayed significant similarity to proteins
containing a C-type animal lectin-like domain (Ya´n˜ez et
al., 1995). The highest optimized FASTA scores were
obtained with sequences on human (Hamann et al.,
1993) and mouse CD69 (Ziegler et al., 1993), vaccinia
virus proteins A40 (Amegadzie et al., 1991) and A34
(Smith et al., 1991), and rat and smallpox virus asyalo-
glycoprotein receptors (Fig. 3A). All the members of this
family contain four highly conserved cysteine residues
responsible for the formation of intramolecular disulfide
bonds.
Moreover, a search of the protein data bases revealed
a significant homology between pEP153R and the CD44
molecules involved in cellular adhesion and T-cell acti-
vation, as can be seen after a multiple alignment of the
amino acid sequence of pEP153R and domains of the
N-terminal region of members of the CD44 family from
different origins (Fig. 3B).
Topology of protein pEP153R
To study the posttranslational processing of protein
pEP153R, and its insertion and orientation into the mem-
brane, the EP153R gene was cloned into the Bluescript
plasmid under the T7 polymerase promoter. Protein
pEP153R was then synthesized in vitro by a rabbit reticu-
locyte system either in the absence or in the presence of
canine pancreatic microsomes, treated by proteinase K
(6Triton X-100), and subjected to sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis (SDS–PAGE). As
shown in Fig. 4, in the absence of microsomes a major
protein of about 18 kDa was synthesized, corresponding
to the predicted size of the polypeptide encoded by
EP153R. Translation in the presence of microsomes
yielded a modified product of about 50 kDa, which
should correspond to a glycosylated form of the protein,
since eight possible sites for N-glycosylation were
present in the C-terminal region of the sequence. Pro-
teinase K treatment of the sample synthesized in the
presence of microsomes rendered a product slightly less
than 50 kDa in size, in contrast with the high level of
sensitivity to protease exhibited by the protein produced
in the absence of microsomes. After solubilization of
microsomes with Triton X-100, the protease treatment
resulted in the disappearance of bands ascribed to
pEP153R. These observations indicate that a small seg-
ment of the N-terminal region of the protein is exposed to
the action of proteases, while the C-terminal domain is
342 GALINDO ET AL.FIG. 1. Nucleotide and predicted amino acid sequence of EP153R ORF. (A) Localization in the ASF virus genome of restriction fragment EcoRI E9
containing EP153R ORF (indicated by an arrow). (B) Sequence of EP153R ORF. Residues corresponding to the putative transmembrane region are
underlined. Potential sites for N-glycosylation are outlined and the RGD motif is highlighted in boldface type. The transcriptional termination motif (T7)
is boxed. (C) Graphic representation of the hydropathy profile of pEP153R obtained by the method of Kyte and Doolittle (1982).
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343AFRICAN SWINE FEVER VIRUS EP153R ORFprotected by the microsomes, supporting the assumption
of pEP153R being a class II integral membrane glyco-
protein with an extracellular C-terminus.
Construction of an ASF virus deletion mutant lacking
EP153R gene
A common approach to study the function of a partic-
ular protein is the generation of virus mutants in which
the gene encoding for that polypeptide is partially or
totally deleted. To analyze the role of the EP153R gene
product in the ASF virus life cycle, a virus recombinant
lacking the EP153R gene, vDEP153R, was generated by
n vivo homologous recombination, using the deletion
lasmid pDEP153R described under Materials and Meth-
ds. This vector was designed to facilitate the replace-
ent of a genomic DNA fragment of 333 bp, covering the
ajority of EP153R, with the marker gene LacZ under the
ontrol of the ASF virus promoter p72 (Figs. 5A and 5B).
eletion mutant viruses were selected and purified as
reviously described (Rodrı´guez et al., 1992). To ensure
hat the vDEP153R genome was as expected, DNA from
he parental virus, BA71V, and DNA from the recombinant
irus, vDEP153R, were purified from infected Vero cells,
igested with EcoRI restriction enzyme, and analyzed by
NA hybridization using two [a-32P]ATP labeled probes:
(i) the EP153R gene, obtained from the Bluescript-
EP153R plasmid digested with BamHI and EcoRI restric-
FIG. 2. Transcriptional analysis of EP153R. (A, B) Autoradiograms of
) and ASF virus-induced immediate-early (lanes C), early (lanes A), a
rrelevant DNA sequencing reaction (DNA ladder) used as a size mark
f early (F) and late (E) transcription initiation sites. (D) Map of EP153R
Transcripts of 1 to 2.7 kb are represented by dashed arrows. The positi
consecutive thymidilate residues (7T) are also indicated.tion enzymes, and (ii) the LacZ gene obtained from the
pINSbgal plasmid (Rodrı´guez et al., 1992) digested withBamHI restriction enzyme. As expected, the EP153R
probe recognized one EcoRI fragment of 8.9 kb in the
sample corresponding to BA71V and two EcoRI frag-
ments of 7.5 and 4.1 kb in the sample corresponding to
vDEP153R, while the LacZ probe recognized the two
EcoRI fragments of 7.5 and 4.1 kb in the sample corre-
sponding to vDEP153R and nothing in the sample corre-
sponding to the parental virus (Fig. 5C). These results
demonstrated that the genomic structure of the ASF virus
deletion mutant was as predicted.
Identification of the EP153R polypeptide in ASF
virus-infected cells
To analyze the expression of pEP153R during the virus
infection cycle, a rabbit antiserum was raised against a
synthetic peptide specific for this protein (Materials and
Methods). First we studied the kinetics of pEP153R ex-
pression in infected cells. Vero cell cultures were in-
fected with BA71V and collected at different times after
virus infection, to be analyzed by Western blot using the
anti-pEP153R antiserum (Fig. 6A). As expected from the
in vitro expression data, a protein of about 50 kDa was
specifically recognized from 6 hpi and accumulated up to
22 hpi. The protein pEP153R was also detected at 16 hpi
in the presence of citosine arabinoside, although in a
lesser amount than in the absence of inhibitor, indicating
that the protein was expressed at both early and late
extension (A) and RNA hybridization (B) of mock-infected cells (lanes
RNA (lanes L) are shown. Samples in A were separated alongside an
size of the relevant DNA fragments is indicated. (C) Precise location
s (thin arrows) within the EcoRI E9 fragment of the ASF virus genome.
RFs (heavy arrows) and the distribution of stretches of seven or moreprimer
nd late
er. The
mRNAtimes in the infection virus cycle, in agreement with the
results obtained by Northern blot and primer extension
v
f
p
a
b amino
m
344 GALINDO ET AL.experiments (Fig. 2). Considering the data obtained by in
FIG. 3. Homology of protein pEP153R with C-type animal lectins and
artial sequences of human and mouse CD69, vaccinia virus protein
lignment of pEP153R with the N-terminal region of human, horse, rat, b
y using the ClustalW program. The numbers on the right indicate the
olecules (asterisks) or equivalent in all of them (dots) are indicated.itro expression, and the presence of eight putative sites
or N-linked carbohydrates in pEP153R, the glycosylationof the protein was also investigated. Cultures of Vero
D44 molecules. (A) Multiple alignment of pEP153R (aa 67 to 153) with
nd rat and smallpox virus asyaloglycoprotein receptors. (B) Multiple
mouse, and hamster CD44 molecules. The alignments were generated
acid positions. Residues in EP153R identical to those in at least threewith C
A40, a
ovine,cells were infected with either BA71V or vDEP153R, in the
presence or in the absence of tunicamycin, and collected
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345AFRICAN SWINE FEVER VIRUS EP153R ORFat 24 hpi to be analyzed by Western blot with the anti-
pEP153R antiserum (Fig. 6B). As expected, the protein of
;50 kDa recognized in samples of BA71V-infected Vero
cells was replaced, in the presence of tunicamycin, by a
polypeptide with the predicted size (18 kDa) for the
EP153R primary translation product, which might corre-
spond to the nonglycosylated form of the protein. Accord-
ingly, this protein was not found in cells infected with
vDEP153R, demonstrating that the gene had been effi-
ciently inactivated. These analyses revealed that the
FIG. 4. In vitro transcription and translation of the EP153R gene. For
nalysis of cotranslational processing, canine pancreas microsomes
ere added to the reaction mixture. Samples were treated with pro-
einase K, in the absence or in the presence of Triton X-100, and
nalyzed by SDS–PAGE. The migration position of molecular size mark-
rs (in kDa) are indicated. Major gene products are indicated by arrows
n the right. Control samples of glycosylation of a-mating factor gene
from S. cerevisae (instead of viral EP153R gene) are shown on the left.
FIG. 5. Characterization of the genomic structure of the ASF virus rec
structure of the parental virus BA71V and that predicted for the recomb
the virus promoter p72 (gray box), into the EP153R ORF (solid box), is i
Vero cells infected with either BA71V or vDEP153R was digested with EcoRI, su
filters, before hybridization to 32P-labeled probes corresponding to EP153R orEP153R gene encodes a glycoprotein present at both
early and late times during virus infection.
EP153R is not required for in vitro replication of ASF
virus
The achievement of a deletion mutant in EP153R gene
is a fair proof of its nonessentiality for in vitro virus
nfection. In fact, the growth curves obtained either in
ero cells or in swine macrophages with both vDEP153R
nd BA71V were equivalent when titrated by plaque
ssay (data not shown). To test the possibility that the
P153R gene could be involved in the determination of
ost range and tissue tropism, we infected up to 17 cell
ines from different sources with either vDEP153R or
A71V and compared the infective virus production at 24
pi in each system. As shown in Fig. 7, only minor
ifferences were observed in the total virus productivity
stimated for both viruses in each cell, and all the lines
aintained their characteristics of sensitivity or resis-
ance to the ASF virus when infected with the EP153R
eletion mutant.
rotein pEP153R is required to develop the
emadsorption process in ASF virus-infected cells
In preliminary experiments it was observed that the
irus produced in swine macrophage cultures infected
y vDEP153R was very difficult to titrate by hemadsorp-
ion assay, although the virus cycle seemed to proceed
orrectly as estimated by the development of cytopathic
ant vDEP153R. (A) Deletion plasmid for the EP153R gene. (B) Genomic
DEP153R. The insertion point of the LacZ gene (striped box), fused to
d. (C) Genomic analysis of recombinant vDEP153R. DNA purified fromombin
inant v
ndicate
bjected to agarose gel electrophoresis, and blotted onto nitrocellulose
LacZ genes. The sizes of detected DNA fragments are indicated.
346 GALINDO ET AL.effect and the infective virus production evaluated by
plaque assay. To study the capacity of vDEP153R to
induce the hemadsorption process, Vero cells and swine
macrophages were infected with either vDEP153R or
BA71V. At 12 hpi swine erythrocytes were added to the
cultures and the formation of hemadsorption rosettes on
infected cells was then monitored by light microscopy
until 3 to 4 days after infection. At 24 hpi nearly all the
cells in cultures infected with BA71V were covered by a
considerable number of erythrocytes (Figs. 8C and 8D), a
FIG. 6. Expression of pEP153R and pEP402R. (A) Kinetics of expres-
sion of pEP153R in infected cells. Vero cell cultures were infected with
BA71V at a m.o.i. of 5 PFU per cell, in the presence or in the absence
of citosine arbinoside (CAR), collected at different times after infection,
and analyzed by Western blot with anti-pEP153R serum, as described
under Materials and Methods. (B) Glycosylation of pEP153R in infected
cells. Vero cells were mock-infected (M) or infected with either BA71V
or vDEP153R, in the presence (1) or in the absence (2) of 1 mg/ml
tunicamycin (Tunic). Cell extracts were prepared at 24 hpi and analyzed
by Western blot with anti-pEP153R serum. (C) Kinetics of expression of
pEP402R and pEP153R in infected cells. Vero cells were mock-infected
(M) or infected with either BA71V or vDEP153R, collected at different
times after infection, and analyzed by Western blot with either anti-
pEP402R or anti-pEP153R serum. The migration positions of molecular
size markers (in kDa) are indicated.process that was specific for ASF virus-infected cells
(see the mock cultures in Figs. 8A and 8B). Infection ofsensitive cells with vDEP153R resulted in a drastic re-
duction both in the percentage of cells showing hemad-
sorption and in the number of erythrocytes per cell in the
rosette (Figs. 8E and 8F), which almost disappeared
when infection was allowed to proceed until 72 hpi.
These observations were extended to a number of ASF
virus-sensitive cell lines (CV2, LLCMK2, and BHK) with
similar results (not shown).
It has been described previously that the EP402R gene
of the ASF virus, which encodes a protein homolog of the
adhesion molecule CD2, is responsible for the hemad-
sorption phenomenon in virus-infected cells (Rodrı´guez
et al., 1993). As the EP402R gene is contiguous with the
EP153R gene in the ASF virus genome (Fig. 2D), we
analyzed the nucleotide sequence of a region in the
vDEP153R genome including the EP402R ORF, 140 nu-
cleotides upstream from the initiation codon and 200
nucleotides downstream from the termination codon.
The results confirmed that the region sequenced was
identical in both BA71V and vDEP153R viruses. We also
analyzed the expression of the EP402R gene in Vero
cells infected with either BA71V or vDEP153R, using a
pEP402R-specific antiserum (F. Almaza´n, manuscript in
preparation). As shown in Fig. 6C, the specific antiserum
recognized a protein that was expressed with kinetics
and at a level similar to those in cells infected with either
the BA71V parental virus or the deletion mutant
vDEP153R. As a control, the same extracts were probed
in parallel against the pEP153R antiserum, confirming
the presence of pEP153R from 7 hpi in samples infected
with BA71V and its absence in cultures infected by
vDEP153R. Minor differences in pEP402R band intensity
could be explained by slight variations in the total protein
loaded on the gel, as can be noticed by comparing the
signal of a protein band of about 55 kDa that was rec-
ognized in all the samples by the pEP153R antiserum
(Fig. 6C, bottom). Considering that the sequence of the
EP402R gene (and nearby regions) was identical in both
BA71V and vDEP153R isolates, and that the protein
pEP402R was correctly expressed during infection with
recombinant virus vDEP153R, we conclude that the de-
letion of the EP153R gene resulted in the loss of the
ability of the ASF virus to induce the hemadsorption
phenomenon.
DISCUSSION
The EP153R gene, located within the EcoRI E9 frag-
ment of the BA71V strain of ASF virus, encodes a
polypeptide of 153 amino acids, predicted to be a class
II transmembrane protein. The presence of eight putative
sites for N-glycosylation indicates that the mature protein
is likely to be highly glycosylated and that its apparent
size will probably be larger than predicted. In fact, in vitro
synthesis of pEP153R in a rabbit reticulocyte system in
the presence of canine microsomes generated a protein
say at
347AFRICAN SWINE FEVER VIRUS EP153R ORFof about 50 kDa, which turned to 18 kDa in the absence
of posttranslational modifications. A similar behavior
was observed in BA71V-infected Vero cell extracts pro-
duced in the absence or in the presence of tunicamycin
and analyzed by Western blot with an antiserum specific
for pEP153R: a polypeptide of 18 kDa, synthesized when
glycosylation was inhibited, changed to 50 kDa when the
infection was performed in the absence of tunicamycin.
On the other hand, results obtained by proteinase K
treatment indicated that only a portion in the N-terminal
region of the protein was exposed to the protease action,
while the C-terminal domain was protected by the micro-
somes, suggesting that pEP153R is a class II integral
membrane glycoprotein with a C-terminal region ex-
posed to the extracellular environment.
The EP153R gene is transcribed both during the early
and the late phases of the infectious cycle, with two
different transcription initiation sites, one for late tran-
scription, close to the translation initiation codon, and the
other for early transcription, at 164 nucleotides from the
translation initiation codon. As expected from these re-
sults, by using an antiserum specific for a pEP153R
peptide, we could detect the pEP153R at early times (6
hpi) in BA71V-infected Vero cells and its subsequent
accumulation until 22 hpi.
The comparative analysis of sequences in the data
bases showed that pEP153R contains a C-type animal
lectin-like domain and a cell attachment (RGD) se-
quence, as previously described (Ya´n˜ez et al., 1995). In
addition, a significant homology was observed between
pEP153R and the N-terminal region of CD44 molecules
involved in cellular adhesion and T-cell activation. This
hydrophilic N-terminus contains the hyaluronic acid
FIG. 7. ASF virus productivity on cell lines infected with BA71V or vDEP
or vDEP153R, and infective virus production was titrated by plaque as
BA71V-infected Vero cell cultures.binding domain (Peach et al., 1993). Antibodies against
CD44 have been shown to inhibit the interaction be-tween human and sheep erythrocytes and T-lympho-
cytes (Hale et al., 1989; Shimizu et al., 1989; Sugimoto et
al., 1994), a phenomenon known as E-rosette formation,
generated by the interaction between CD58 (LFA-3) and
CD2 molecules present in the red and white cells, re-
spectively. It has been suggested that the physical prox-
imity of CD44 to erythrocyte LFA-3 molecules may be
required to regulate the LFA-3–CD2 interaction (Haynes
et al., 1989). In the case of ASF virus-induced hemad-
sorption, a viral CD2 homolog, encoded by the EP402R
gene, is responsible for the adhesion of swine erythro-
cytes to infected cells (Rodrı´guez et al., 1993); however,
the corresponding ligand in the red blood cell is un-
known.
A viable deletion mutant lacking the majority of the
EP153R ORF was constructed. No differences in growth
kinetics or virus production were detected when the
parental virus and the deletion mutant were compared,
providing evidence of the nonessentiality of the EP153R
gene for in vitro ASF virus infection. Dispensable genes,
however, can be involved in the enhancement of virus
infectivity, for example, by protecting the virus particles
from the host response or by extending the host range
and tissue tropism in in vivo infections. The results ob-
tained when comparing total virus productivity in 17 es-
tablished cell lines from various sources, infected by
either BA71V or vDEP153R, did not reveal any evidence
of the possible involvement of the EP153R gene in the
determination of cell susceptibility to the ASF virus. How-
ever, in the process of evaluation of virus yields by
hemadsorption assays, a considerable difficulty was
noted in the development of rosettes around cells in-
fected by vDEP153R. The results presented in this paper
uplicate cultures of different cell lines were infected with either BA71V
24 hpi. Data are represented as percentage of the virus produced in153R. Dproved that the inactivation of the EP153R gene induced
a drastic reduction both in the proportion of infected cells
348 GALINDO ET AL.FIG. 8. Effect of EP153R gene deletion on the hemadsorption induced by ASF virus. Cultures of Vero cells (A, C and E) and swine alveolar
macrophages (B, D and F), mock-infected (A and B) or infected with either BA71V (C and D) or vDEP153R (E and F), were incubated with swine
erythrocytes to develop the hemadsorption process on virus-infected cells.
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349AFRICAN SWINE FEVER VIRUS EP153R ORFsurrounded by swine erythrocytes and in the number of
erythrocytes attached per infected cell. It has been pre-
viously described that disruption of the EP402R gene,
which encodes a CD2 homolog and is contiguous with
the EP153R gene, also inhibits the hemadsorption phe-
nomenon induced by ASF virus infection (Rodrı´guez et
l., 1993). Our results showed that the sequence of the
P402R gene in the deletion mutant vDEP153R was iden-
ical to that in the parental virus BA71V and that the
inetics and level of expression of the viral CD2 homolog
ere equivalent in cells infected either with BA71V or
ith vDEP153R, indicating that the CD2 homolog was
roperly synthesized by the recombinant virus. Previous
esults in our laboratory stated that the expression of the
acZ gene, inserted into the thymidine kinase gene of
he ASF virus genome, had no inhibitory effects on the
nduction of hemadsorption (Rodrı´guez et al., 1993). In
addition, and in contrast to EP402R, expression of the
EP153R gene as a recombinant product in heterologous
eukaryotic systems, like Baculovirus or Sindbis
pseudovirus, did not induce the hemadsorption process
(data not shown).
Considering all the data presented here, our conclu-
sion is that pEP153R is probably involved in the hemad-
sorption induced in ASF virus-infected cells, presumably
as a stabilizer of the interaction between the viral CD2
homolog exposed in the virus-infected cell plasma mem-
brane and its corresponding ligand in swine erythro-
cytes. This type of hemadsorption-negative virus mutant
represents a useful and convenient tool with which to
understand the biological relevance of the hemadsorp-
tion process in in vivo ASF virus infections, which man-
ifest, among other characteristics, several hemostatic
abnormalities and consumption coagulopathies associ-
ated with the disease (Villeda et al., 1993a,b). Further
characterization of proteins like pEP153R, which may
interact with erythrocytes, lymphocytes, monocytes, ad-
hesion molecules related to the immune system, plate-
lets, cellular integrins, and caspases (via RGD se-
quence), will help us to understand the biology of the
ASF virus infection.
MATERIALS AND METHODS
Cells and viruses
All the established cell lines used throughout this
report were seeded from working stocks kept in storage
in our laboratory and can be obtained from the American
Type Culture Collection, with the exception of SY5Y
(Biedler et al., 1978) and BHK (Invitrogen). Swine alveolar
macrophages were prepared by broncho-alveolar lavage
as described (Carrascosa et al., 1982). Mammalian cells
were cultured at 37°C in Dulbecco’s modified Eagle’s
(DME) medium supplemented with 5% newborn calf se-
rum (for Vero cells), 10% homologous swine serum (for
swine macrophages), or 5% heat-inactivated fetal calf
s
iserum (for the rest of the cells). Insect cells were main-
tained at 27°C in TC100 medium supplemented with 10%
heat-inactivated fetal calf serum.
The Vero-adapted ASF virus strain BA71V was propa-
gated and titrated either by plaque assay on Vero cells or
by hemadsorption on alveolar swine macrophages, as
previously described (Enjuanes et al., 1976; Carrascosa
et al., 1982). The ASF virus deletion mutant vDEP153R
was constructed as described below.
Assay of virus production
To assay the ASF virus production in different estab-
lished lines, cell cultures were infected in their corre-
sponding medium with either BA71V or vDEP153R at a
m.o.i. of 10 PFU per cell. After virus adsorption inoculum
was removed, cell cultures were washed twice with
warm medium and then incubated at 37°C. Total virus
was collected at different times after infection and ti-
trated either by plaque assay on Vero cells or by hemad-
sorption on alveolar swine macrophages, as indicated
(Enjuanes et al., 1976).
Preparation and analysis of RNA
Whole-cell RNA was prepared by the TRI-Reagent
(Molecular Research Center, Inc.) method (Chomczynski,
1993) from mock-infected cells from cells infected with
ASF virus (5 PFU per cell) for 8 h in the presence of either
40 mg/ml of cycloheximide (immediate-early RNA) or 100
mg/ml of citosine arabinoside (early RNA), and from cells
infected for 16 h in the absence of drugs (late RNA).
Both the Northern blot and the primer extension anal-
yses were performed as previously described (Rodrı´guez
et al., 1994) using a 32P-end-labeled oligonucleotide
(59-TTCCAATCAATATTCCAATTAATATGTAAC-39), comple-
mentary to nucleotides 90 to 118 of the coding strand of
EP153R.
For Northern blot, 15 mg of each of the different RNAs
as fractionated on formaldehyde agarose gels, trans-
erred to nitrocellulose, and hybridized to the 32P-labeled
probe. For primer extension, after hybridization of the
59-end-labeled primer to 20 mg of the different RNAs, the
amples were extended with avian myeloblastosis virus
everse transcriptase for 2 h at 37°C and then subjected
o electrophoresis in 6% polyacrylamide sequencing
els.
urification and analysis of DNA
Purification of ASF virus DNA was carried out as de-
cribed (Enjuanes et al., 1976). Plasmid DNA purification,
ndonuclease restriction analysis, DNA hybridizations,
nd preparation of radioactive probes were performed
sing standard protocols (Sambrook et al., 1989). DNA
equencing was carried out after PCR amplification of
elected regions of the viral genome by using dideox-
nucleotide terminators (Sanger et al., 1977).
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350 GALINDO ET AL.Plasmid construction
The deletion vector pDEP153R was constructed to
facilitate the replacement of a genomic DNA fragment of
333 bp within the EP153R ORF with the Escherichia coli
marker gene LacZ fused to the ASF virus promoter p72.
A 820-bp HinfI fragment, containing the 59 end of the
EP153R ORF, was obtained from plasmid pBA71V-CD2
(Rodrı´guez et al., 1993), treated with Klenow enzyme, and
cloned into SmaI-cut p72GAL10T (Garcı´a et al., 1995) to
generate plasmid p72GAL10TL. A 1377-bp BsaAI frag-
ment, containing the 39 end of EP153R, was also ob-
tained from plasmid pBA71V-CD2 and cloned into
p72GAL10TL, which had been previously cut with SalI,
and treated with Klenow enzyme to generate the deletion
vector pDEP153R (Fig. 5A).
In vitro transcription and translation
Expression of the EP153R gene in vitro was done by
coupled transcription and translation in the TNT reticu-
locyte lysate system (Promega). The reaction was car-
ried out using [35S]Met/Cys Translabel Mix (Amersham)
at 30°C for 90 min, in the presence or in the absence of
canine pancreatic microsomes (Promega) to assess
posttranslational processing of the EP153R gene prod-
uct. Positive controls of glycosylation with the a-mating
actor (instead of EP153R) gene from Saccharomyces
erevisae were run in parallel. Posttranslational proteol-
sis was performed using 0.5% Proteinase K for 15 min at
oom temperature in the absence or in the presence of
% Triton X-100. Samples were supplemented with PMSF
o a final concentration of 5 mM, subjected to SDS–
AGE, and visualized by autoradiography.
reparation of antibodies
To generate specific antibodies against the ASF virus
rotein encoded by EP153R gene, a 15-amino-acid-long
eptide (MYFKKKYIGLIDKNC), covering the sequence
–15 corresponding to the N-terminal region of the pro-
ein, was synthesized. The peptide was conjugated to
eyhole limpet hemocyanin (Pierce) via C-terminal Cys,
ith the linking agent sulfo-succinimidyl 4-(N-maleim-
domethyl) cyclohexane-1-carboxylate (Brinkley, 1992)
nd used to immunize rabbits. The immune serum ob-
ained recognized pEP153R on Western blots.
estern blot
Protein samples were dissociated in Laemmli (1970)
uffer, electrophoresed in a 7 to 20% polyacrylamide gel
SDS–PAGE), and transferred to nitrocellulose paper. Af-
er being blocked with 1% skim milk in TBS, the mem-
ranes were incubated overnight at 4°C with either anti-
EP153R or anti-pEP402R serum, diluted 1/100 or 1/5000,espectively, in TBS containing 0.1% Tween 20. Bound
ntibodies were detected with a second peroxidase-onjugated antiserum and luminol by the ECL detection
ystem (Amersham) according to the manufacturer’s in-
tructions.
emadsorption assay
Cultures of swine alveolar macrophages or Vero cells
ere infected with either BA71V or vDEP153R at a m.o.i.
f 1 PFU per cell. At 12 hpi swine erythrocytes were
dded to a concentration of 2.5 3 106 cells/ml, and the
anifestation of hemadsorption was monitored from 24
o 48 hpi by phase-contrast microscopy.
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